广济药业 (000952.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(广济药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 180,161,008.71737,819,479.15522,494,180.17343,911,715.83115,290,588.81797,642,746.07674,481,519.91512,876,336.07178,873,451.83
 营业利润(元) -56,186,179.77-141,053,232.43-73,418,280.12-27,995,113.08-45,298,268.9160,781,612.7818,222,605.4527,019,552.168,728,468.35
 利润总额(元) -55,204,442.56-140,666,545.20-73,218,431.40-28,627,530.91-45,818,121.9260,083,091.8717,662,806.9226,230,728.237,709,901.39
 净利润(元) -54,669,434.50-152,414,221.39-71,794,280.01-28,125,785.03-45,398,332.5147,716,604.5618,272,970.7823,237,487.617,655,581.24
 归属于母公司股东的净利润(元) -50,508,221.70-140,248,068.54-66,976,169.88-25,804,539.22-44,038,541.8550,366,243.2319,907,205.6824,696,168.478,356,171.56
盈利能力:
 销售毛利率(%) 16.3727.4028.8330.8118.2837.0034.7033.0632.26
 销售净利率(%) -30.34-20.66-13.74-8.18-39.385.983.416.185.74
 净资产收益率(%) -3.64-9.79-4.59-1.75-3.00----
 总资产报酬率ROA(%) -1.71-3.52-1.66-0.61-1.71----
 投入资本回报率ROIC(%) -2.19-6.27-2.92-1.10-2.052.511.021.310.43
营运能力:
 存货周转率(次) 0.512.061.320.820.39----
 应收账款周转率(次) 0.893.582.441.540.64----
 总资产周转率(次) 0.070.270.190.130.05----
偿债能力:
 资产负债率(%) 55.5854.0453.3354.6741.0339.5837.9833.9937.04
 股东权益比率(%) 43.6045.0145.5245.7359.4660.8662.4566.4763.49
 已获利息倍数(倍) -5.64-2.21-1.68-1.42-8.034.953.225.532.65
 流动比率 1.211.251.441.941.281.541.541.621.52
 速动比率 0.770.840.991.510.871.141.040.971.07
发展能力:
 营业收入增长率(%) 56.27-7.50-2.57-8.54-13.491.5412.5916.30-24.42
 营业利润增长率(%) -24.04-332.07-502.90-203.61-618.97-48.58-77.92-59.08-51.23
 税后利润增长率(%) -14.69-378.64-436.44-204.49-627.02-54.26-73.16-58.65-39.62
 净资产增长率(%) -10.18-9.26-1.480.96-0.562.752.944.116.05
 总资产增长率(%) 22.5122.6535.1646.726.1720.5115.881.9218.76

前瞻产业研究院